Why Big Pharma Is Following Novartis’ Lead In A $25 Billion Market
Investor's Business DailyNovartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.
The post Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market appeared first on Investor&#…